A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)
Clinical trial NCT07300280 · RECRUITING
Trial details
- NCT number
- NCT07300280
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2026-10-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.